Crunching the numbers for TLRY... Refresh in a moment for the full analysis.
Tilray Brands, Inc. (TLRY)
Healthcare
weak
$6.57
Updated: 2026-04-12
38
TradeApes Score
reduce
Financial Strength
35
Weak
Operating Trend
45
Mixed
Valuation
40
Weak
Capital Allocation
30
Weak
Risk
35
Weak
Key Findings
+
Strong revenue growth — sales up more than 20% year over year
−
Weak interest coverage — earnings barely cover debt service
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.